Karagas MR - Search Results

1

History of Parvovirus B19 infection is associated with a DNA methylation signature in childhood acute lymphoblastic leukemia.

Vasconcelos GM, Christensen BC, Houseman EA, Xiao J, Marsit CJ, Wiencke JK, Zheng S, Karagas MR, Nelson HH, Wrensch MR, Kelsey KT, Pombo-de-Oliveira MS, Wiemels JL. Vasconcelos GM, et al. Among authors: karagas mr. Epigenetics. 2011 Dec;6(12):1436-43. doi: 10.4161/epi.6.12.18464. Epigenetics. 2011. PMID: 22139573 Free PMC article.

2

Fas/APO-1 promoter polymorphism is not associated with non-melanoma skin cancer.

Nelson HH, Kelsey KT, Bronson MH, Mott LA, Karagas MR. Nelson HH, et al. Among authors: karagas mr. Cancer Epidemiol Biomarkers Prev. 2001 Jul;10(7):809-10. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11440968 No abstract available.

3

The XRCC1 Arg399Gln polymorphism, sunburn, and non-melanoma skin cancer: evidence of gene-environment interaction.

Nelson HH, Kelsey KT, Mott LA, Karagas MR. Nelson HH, et al. Among authors: karagas mr. Cancer Res. 2002 Jan 1;62(1):152-5. Cancer Res. 2002. PMID: 11782372

4

Microsatellite instability at tetranucleotide repeats in skin and bladder cancer.

Danaee H, Nelson HH, Karagas MR, Schned AR, Ashok TD, Hirao T, Perry AE, Kelsey KT. Danaee H, et al. Among authors: karagas mr. Oncogene. 2002 Jul 25;21(32):4894-9. doi: 10.1038/sj.onc.1205619. Oncogene. 2002. PMID: 12118368

5

A population-based case-control study of the XRCC1 Arg399Gln polymorphism and susceptibility to bladder cancer.

Kelsey KT, Park S, Nelson HH, Karagas MR. Kelsey KT, et al. Among authors: karagas mr. Cancer Epidemiol Biomarkers Prev. 2004 Aug;13(8):1337-41. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 15298955

6

Gender, smoking, glutathione-S-transferase variants and bladder cancer incidence: a population-based study.

Karagas MR, Park S, Warren A, Hamilton J, Nelson HH, Mott LA, Kelsey KT. Karagas MR, et al. Cancer Lett. 2005 Feb 28;219(1):63-9. doi: 10.1016/j.canlet.2004.10.006. Cancer Lett. 2005. PMID: 15694665

7

The XPC poly-AT polymorphism in non-melanoma skin cancer.

Nelson HH, Christensen B, Karagas MR. Nelson HH, et al. Among authors: karagas mr. Cancer Lett. 2005 May 26;222(2):205-9. doi: 10.1016/j.canlet.2004.11.032. Epub 2005 Jan 7. Cancer Lett. 2005. PMID: 15863269

8

Carcinogen exposure and gene promoter hypermethylation in bladder cancer.

Marsit CJ, Karagas MR, Danaee H, Liu M, Andrew A, Schned A, Nelson HH, Kelsey KT. Marsit CJ, et al. Among authors: karagas mr. Carcinogenesis. 2006 Jan;27(1):112-6. doi: 10.1093/carcin/bgi172. Epub 2005 Jun 29. Carcinogenesis. 2006. PMID: 15987713

9

Epigenetic inactivation of SFRP genes and TP53 alteration act jointly as markers of invasive bladder cancer.

Marsit CJ, Karagas MR, Andrew A, Liu M, Danaee H, Schned AR, Nelson HH, Kelsey KT. Marsit CJ, et al. Among authors: karagas mr. Cancer Res. 2005 Aug 15;65(16):7081-5. doi: 10.1158/0008-5472.CAN-05-0267. Cancer Res. 2005. PMID: 16103055

10

Loss of heterozygosity on chromosome 9q and p53 alterations in human bladder cancer.

Hirao S, Hirao T, Marsit CJ, Hirao Y, Schned A, Devi-Ashok T, Nelson HH, Andrew A, Karagas MR, Kelsey KT. Hirao S, et al. Among authors: karagas mr. Cancer. 2005 Nov 1;104(9):1918-23. doi: 10.1002/cncr.21423. Cancer. 2005. PMID: 16149093 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

557 results

Search Page